Neoplasms Flashcards

1
Q

Why do tumours arise?

A

Due to accumulation of multiple genetic alterations (mutation, deletion, translocation) and epigenetic changes (methylation) in cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do these changes result in?

A

Abnormal (neoplastic) growth - forming mass of tumour cells that persists in the absence of the initiating causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The structure of neoplastic cells comprise of…

A

Neoplastic cells and connective tissue stroma (provides vascular supply for growth).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What makes neoplasms malignant?

A

Possess abnormal characteristics, i.e.:
- invade other tissues
- metastasise to other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Frequent malignancies in the UK

A

Lung CA
Colorectral CA
Breast CA + Prostate CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of the stroma?

A

Mechanical support
Intracellular signalling
Nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The process of stroma formation

A

Desmoplastic reaction (fibrous) due to induction of CT fibroblast proliferation by GFs from the tumour cells. = CANCER-ASSOCIATED FIBROBLASTS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In which type of CA are myofribroblats particularly abundant?

A

Breast CA - contractility= puckering and retraction of adjacent structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What induces angiogenesis in tumours?

A

VEGF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What opposes the action of VEGF?

A

Angiostatin and endostatin. ? potential in CA therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the different shapes of tumours on a surface (i.e. GIT)?

A

Gross appearance can be:
- sessile
- polypoid (benign)
- papillary
- exophytic/fungating
- ulcerated (malignant)
- annular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How neoplasms differ?

A
  • loss/reduction of differentiation
  • loss/reduction of cellular cohesion
  • nuclear enlargement, hyperchromasia and pleomorphism
  • increased mitotic activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What two factors are used in tumour classification?

A

Behaviour and histogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Principle characteristics of benign tumours:

A

Growth rate: slow

Mitoses: infrequent

Histological resemblance to normal tissue: good

Nuclear morphology: near normal

Invasion: no

Metastases: never

Border: often circumscribed or encapsulated

Necrosis: rare

Ulceration: rare

Direction of growth on skin or mucosal surfaces: exophytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Principle characteristics of malignant tumours:

A

Growth rate: relatively rapid

Mitoses: frequent + atypical

Histological resemblance to normal tissue: variable, often poor

Nuclear morphology: Usually enlarged, hyperchromatic, irregular outline, multiple nucleoli, and pleomorphic (variable size and shape)

Invasion: yes

Metastases: frequent

Border: often poorly defined or irregular

Necrosis: common

Ulceration: common on skin or mucosal surfaces

Direction of growth on mucosal surfaces or skin: endophytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What clinical problems may arise from benign tumours?

A

Pressure on adjacent tissues.

Obstruction to the flow of fluid.

Production of a hormone.

Transformation into malignant neoplasm.

Anxiety.

17
Q

Histogenic classification

A

By tissue or cell of origin.

Histological resemblance to parent tissue allows for grading -> correlates with clinical behaviour.

18
Q

What are the major categories of histogenetic classification?

A

Carcinomas: epithelial tissue
Sarcomas: connective tissue
Lymphomas/leukaemias: lymphoid or haemopoietic organs.

19
Q

Malignant tumours degree of differentiation:

A

1 - well differentiated
2 - moderately differentiated
3 - poorly differentiated

20
Q

Benign epithelial and connective tissue tumours:

A

Papillomas (transitional or stratified squamous) and adenomas (glandular or secretory epithelium).

21
Q

Malignant epithelial and connective tissue tumours:

A

Carcinomas (non-glandular) adenocarcinoma (glandular) and sarcomas.

22
Q

Carcinoma in situ

A

Malignant - has not invaded through the basement membrane.

23
Q

A malignant lymphoma characterised by the presence of Reed-Sternberg cells

A

Hodgkin’s lymphoma

24
Q

Teratoma

A

Neoplasm of germ cell origin - all three germ layers.

25
Q

Blastomas

A

Arise in those below the age of 5.

  • Retinoblastoma
  • Nephroblastoma (Wilm’s tumour)
  • Neuroblastoma (adrenal medulla or nerve ganglia
  • Hepatoblastoma
26
Q

Mixed tumours

A

Characteristics combination of cell types - mixed parotid tumour.

27
Q

Endocrine tumours

A

From peptide hormone-secreting cells scattered diffusely in various epithelial tissue.

Insulinoma
Gastrinoma

Exceptions: medullary carcinoma of the thyroid gland - calcitonin producing.

Phaeochromocytome: adrenal medulla.

28
Q

Hamartomas

A

Tumour-like lesion - lacks autonomy of true neoplasm.

Pigmented naevi or adenochrondroma in lungs.

29
Q

Cysts

A

Fluid-filled space lined by epithelium.

Cysts types are:
Neoplastic (cystic teratoma)
Congenital (branchial cyst)
Parasitic (hydatid cysts)
Retention (pilar cysts)
Implantation (surgical)

30
Q

Neoplastic cells are…

A

Relatively or absolutely autonomous.

Unresponsive to extracellular growth factors.

Showing self-sufficiency in growth signalling.

Evade apoptosis.

Frequently have genomic instability.

Tumour products include fetal substances and unexpected hormones.

31
Q

Immortality of CA cells is due to…

A

Oncogenes + tumour supressor genes

Reduced apoptosis

Telomerase

32
Q

Genomic instability in tumour cells.

A

Nuclear hyperchromasia= exact multiples or chrosome gains/losses.

Pleomorphism

Translocation - Philadelphia chromosome t(9;22) CML.

33
Q

Mitotic figures in malignant tumours.

A

Abundant, grossly abnormal figures.

34
Q

Small cell carcinoma of the lungsecrete:

A

Substances inappropriate of their origin: ACTH and ADH.